20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page
Recommended Webinars & Conferences
Journal Flyer
Flyer image

Maximino Redondo

Maximino Redondo

Maximino Redondo
University of Malaga, Hospital Tumor Registry, Spain


He has received his MD and PhD in Biochemistry from the University of Granada Spain and completed his residency training in Clinical Biochemistry in Virgen de las Nieves University Hospital Granada. He is Associate Professor in the Department of Biochemistry and Molecular Biology University of Malaga Spain.  He also obtained the following accreditations: European Clinical Chemist European Communities Confederation of Clinical Chemistry Accreditation in Human Genetic Spanish Association of Human Genetic and University Expert in Epidemiology and Clinical ResearchUniversity of Granada.  He is Director of Hospital Tumor Registry Marbella Spain and Member of the European Association of Cancer Research. He has served as Principal Investigator on 15 grants and he is author of 65 articles 10 books and present 130 papers at National and International Scientific Meetings. He served as journal referee for: British Journal of Cancer European Journal of Surgical Oncology,  Neoplasia Tumor Biology,  Journal of Cellular and Molecular Medicine,  Investigational New Drugs Current Medical Chemistry,  Supportive Care in Cancer Patient Preference and Adherence eBooks from Bentham Science. He was honoured as a Visiting Professor in the Department of Pathology,  University of Miami USA and he has received 12 Awards from different Scientific Associations.

Research Interest

Implication in tumorigenesis and regulation of apoptosis-related genes. Influence of tumor biology in the relationship between diagnostic delay and prognosis in cancer patients.Tumor immunology. Screen-detected breast cancer: differences in biology and survival.